Trial Profile
High loading dose of rosuvastatin in ACS patients undergoing PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2013
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders
- Focus Therapeutic Use
- 21 Aug 2013 New trial record
- 01 Jul 2013 Primary endpoint 'Major-adverse-cardiac-event-rate' has been met.